Back

Short-term outcomes during the blanking period after catheter ablation using a novel circular pulsed field ablation system in patients with atrial fibrillation

30 March 2025 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 1: atrial tachyarrhythmias Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Joerg Yogarajah

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

156 More presentations in this session

Presentation thumbnail
Native left atrial tachycardias clinical and electrophysiological characteristics: insights from a national survey.
Doctor S. Bun (Nice, FR)
Abstract
Presentation thumbnail
A novel immersive catheter ablation simulator based on individualized 3D MR patients' heart models improves ablation performance of future electrophysiologists.
Ms N. Bacha (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Safety and feasibility of same day discharge catheter ablation: initial German experience
Doctor S. Popescu (Luebeck, DE)
Abstract
Presentation thumbnail
Safety, obstetric and neonatal data trend of novel arrhythmia management in pregnant: zero-fluoroscopy catheter ablation vs. antiarrhythmic drugs
Doctor Z. Suleymen (Astana, KZ)
Abstract Slides Video
Presentation thumbnail
Sensor-enabled 3D electroanatomical model optimization in in-vivo porcine and benchtop models
Mr G. Wenzel (Minneapolis, US)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1: atrial tachyarrhythmias

The Event

Event poster

EHRA 2025

30 March 2025 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Feasibility and procedural safety of the pentaspline pulsed field ablation catheter for atrial lesions beyond pulmonary vein isolation
thumbnail
Congress Presentation
Comparative analysis of pulsed-field and cryoballoon ablation in octogenarians with atrial fibrillation: a multicenter study
thumbnail
Congress Session
New developments in catheter ablation of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources